Clinical trials
Phase 3 Essential Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
119 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 8 |
| 2008 | 7 |
| 2009 | 6 |
| 2010 | 7 |
| 2011 | 12 |
| 2012 | 8 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 11 |
| 2023 | 4 |
| 2024 | 11 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 102 |
| Unknown status | 11 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 12 |
| Boryung Pharmaceutical Co., Ltd | 10 |
| Novartis Pharmaceuticals | 8 |
| Chong Kun Dang Pharmaceutical | 7 |
| Daiichi Sankyo | 7 |
| Novartis | 7 |
| Addpharma Inc. | 5 |
| Sankyo Pharma Gmbh | 5 |
| Bayer | 4 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 119 |
| Hypertension | 48 |
| Cardiovascular Diseases | 9 |
| Vascular Diseases | 5 |
| Dyslipidemias | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Hypercholesterolemia | 2 |
| Atherosclerosis | 1 |
| Atrial Fibrillation | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 1 to 25 of 119. Each trial links to its page on Pharma Observatory.
19 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.